Immuno-Oncology 360° Community News’ Post

Gain insights at #ELCC24 as we present a 4-year exploratory analysis from lead author Professor Martin Reck; how is the quality of survival for patients with metastatic #NSCLC affected by dual #immunotherapy + chemo vs chemo?

B cell depletion is one of the most efficient treatment regimen in #multiplesclerosis, yet its clinical efficacy remains largely enigmatic. In our recent study led by Can Ulutekin and Galli Edoardo at the Becher lab of the University of Zurich we performed longitudinal profiling of MS patients undergoing B cell depletion. We uncovered B cell/T cell interactions mediated by the CD27/CD70 axis as potential driver of the clinical efficacy of B cell depleting therapies. Many thanks to all our valuable collaborators and the patients that donated samples for this study! Paper: https://lnkd.in/eWP_aU_k X-torial: https://lnkd.in/eK2SuGeE

Today, on #WorldBrainTumorDay, let's unite to raise awareness about brain tumors and stand in solidarity with those affected. Brain tumors can arise in the brain itself or migrate from other parts of the body. #Earlydetection and comprehensive treatment, coupled with rehabilitative support, are critical for enhancing the quality of life for patients. TRUPCR® offers RT-PCR based assays for diagnosis of markers responsible for #braintumor. To know more, write to us at info@3bblackbio.com.

The threat of radiation extends beyond the risks of cancer, cataracts, skin lesions, and hypertension. Are you also watching your back?  The time is now to safely #ShedTheLead.       Rampart is proud to partner with Optima Education Ltd to build awareness and provide education for #RadiationSafety and #OrthopedicProtection. You can help us better understand the impacts to those who work in the interventional suite by participating in a short survey from Optima here: https://lnkd.in/gKvnKyxa  #ProtectTheTeam #YouAreWorthIt

Today is World Cholangiocarcinoma Day. It's a day to "raise much-needed awareness" of CCA & advocate for a "smoother journey to diagnosis," according to the Global Cholangiocarcinoma Alliance. Don't miss this insightful new article on CCA by our contributor Amanda Brink, DNP, APRN, FNP-BC, AOCNP, who discusses the importance of molecular testing for these patients: https://buff.ly/49gUZKK #WorldCCADay #BeClearOnCCA

Hear it from the experts

The extracellular matrix (ECM) is more than just a structural scaffold for tissues. Recent research highlights its many other functions, including critical roles in cell migration and cell fate. But what happens when the ECM is disrupted? The consequences include inflammation, protein post-translational modifications (PTMs), and disease. Join us at #ECM2024 on June 17, 2024, at 4:35 PM, to learn how to detect these aberrant ECM changes early with just a drop of blood. Dr. Molly Coseno, Scientific Support Manager at Sengenics, will discuss leveraging autoantibody profiling to gain direct insights into immune dysfunction caused by ECM disruption, including citrullination — a PTM associated with inflammation. Can’t attend her talk? Learn more about citrullination in our detailed white paper: https://lnkd.in/e783jnUV Or, connect with our experts today at https://lnkd.in/e22dvB6Q #ExtracellularMatrix #CancerResearch #PostTranslationalModifications #PrecisionMedicine #Biomarkers

🔬 Insights from ASCO 2024! Prof Mariana Brandao from Institut Jules Bordet presents the latest ctDNA analysis from the ADAURA trial on adjuvant osimertinib in resected stage I-III NSCLC. The study suggests that ctDNA monitoring could help tailor treatment duration, potentially reducing toxicity and improving patient quality of life. Discover the implications for clinical practice. Discover these updates.👇 For all ASCO 2024 videos, find the link in the comments! #MediMix #ASCO2024 #LungCancer #OncologyInnovation #ADAURATrial #ctDNA

Eurogin, The Leading International Multidisciplinary HPV Congress. Started in 1993 as a conference where scientific progress and clinical practice converge, EUROGIN shares translational research with an international scientific community aiming at accelerating the reduction of the burden of HPV-related cancers and their mortality. #Bioperfectus Fully automated Extraction systems SAW-48 showcase in Eurogin,Sweden. Offer a fully Automated solutions for #HPV, #STI testing.

In the realm of healing, where hope takes flight, Losartan emerges, a beacon of light. For those with leukemia, in battles so tough, This medication’s touch makes the path less rough. It targets AGTR1, a receptor so bold, Inhibiting its power, breaking its hold. Cancer’s growth disrupted, its strength fades away, Chemotherapy’s might now holds greater sway. In men and women, the difference is clear, Survival rates rise, a tale we hold dear. Losartan’s shield guards the heart with care, In this fight for life, it stands ever fair. A promise of hope, in each patient’s eyes, With losartan’s aid, their spirits rise. A testament to science, a work of art, For leukemia patients, a hopeful start. ———— Giving cancer patients losartan could make their chemotherapy treatments more effective and protect them from potential heart damage, according to a new analysis published in Science Translational Medicine.[1]